Key Highlights
- Domo delivered Q4 EPS of $0.03, surpassing analyst expectations of -$0.03 by $0.06
- Quarterly revenue reached $79.63M, exceeding the projected $78.65M
- Shares currently trade at $4.38, reflecting a 74% decline across six months, hovering near the 12-month floor of $3.45
- Citizens maintained its Market Underperform stance with a $3.50 target, highlighting leverage and competitive challenges
- The company maintains approximately $126M in borrowings at 12.2% interest, alongside $43M in available cash
Domo delivered unexpected profitability during its fourth quarter of fiscal 2026, defying Wall Street projections. The cloud-based business intelligence provider reported earnings of $0.03 per share, compared to the anticipated loss of $0.03 per share — marking a $0.06 positive variance.
Domo $DOMO +36.7% After-Hours on big earnings beat:
Rev $79.63m v est $78.62m
Adj EPS $0.03 v est -$0.03 (big beat)
Adj Operating Income: $8.13m v est $3.86m
Operating Margin -13.3%, up from -15.6% same quarter last year Billings $111.2m, up 8.4% y/y https://t.co/3meeFaqOhQ pic.twitter.com/n5WrKveG7f— Traders Community (@TradersCom) March 11, 2026
Quarterly sales totaled $79.63 million, exceeding analyst forecasts of $78.65 million. Both performance metrics came in ahead of expectations.
Shares climbed $0.11 during the session to reach $4.38, with trading volume around 1.75 million shares — surpassing the typical daily average of 1.27 million. Taking a broader view reveals more challenging trends.
The stock has declined approximately 74% over the preceding half-year period. The 12-month peak stands at $18.49. Current trading levels remain substantially beneath both the 50-day moving average of $5.68 and the 200-day moving average of $10.47.
Following the earnings release, Citizens maintained its Market Underperform designation along with a $3.50 price objective. This target falls below present trading levels.
Leverage Creates Primary Risk Factor
Citizens emphasized Domo’s borrowing position as a significant concern. The business maintains a credit arrangement totaling approximately $126 million with a 12.2% interest rate, scheduled to mature in August 2028. The company holds $43 million in available cash reserves.
This configuration produces a current ratio of 0.57 — indicating near-term liabilities surpass readily available assets. The margin for maneuver appears limited.
The credit facility includes performance requirements. Domo must achieve minimum annual recurring revenue of $285 million by the conclusion of fiscal Q4 2026, increasing to $290 million by the end of fiscal Q1 2027. The company must also sustain adjusted EBITDA of at least $12.1 million and $15.2 million at these respective milestones.
A separate liquidity requirement mandates Domo maintain no less than $25 million in unrestricted cash within U.S.-based pledged accounts.
Market Rivalry Intensifies
Citizens also highlighted competitive pressures. Domo functions within the Snowflake ecosystem, where it encounters challenges from competitors such as Sigma Computing.
Sigma revealed at the Citizens Technology Conference last week that it reached $200 million in annual recurring revenue — approximately doubling on a year-over-year basis. Such expansion rates underscore the intensifying competitive landscape.
Analyst perspectives on Domo remain divided. TD Cowen reduced its target from $16 to $9 while maintaining a Buy rating. Citigroup shifted its stance from Outperform to Underperform in February. Lake Street and Wall Street Zen both adopted Hold positions.
Cantor Fitzgerald stands apart, preserving an Overweight rating alongside a $22 price target.
The overall analyst consensus registers as “Hold” with a collective price target of $12.07 — nearly triple the current share price.
Regarding ownership structure, institutional investors control 76.64% of outstanding shares. Goldman Sachs expanded its stake by 22.5% during the most recent quarter. AQR Capital Management boosted its holdings by 17.5%.
The equity carries a market capitalization of $183 million, a P/E ratio of -2.56, and a beta coefficient of 1.70. The 12-month low stands at $3.45.

